Apr 16, 2020
63:61
For every 61 shares held, investors received 63. The price per share adjusted from $26.40 to $25.56.
The split itself did not change the total investment value.
Enimmune corporation (TPEX:6564) operates in the Biotechnology industry.
Enimmune corporation company overviewEnimmune corporation's most recent stock split was on April 16, 2020. It was a 63-for-61 forward split, so shareholders received 63 shares for every 61 they held.
Enimmune corporation has split its stock once. This history records one forward split, on April 16, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Enimmune corporation's 63-for-61 split on April 16, 2020, every 61 shares became 63 shares.
Enimmune corporation has not announced a new split in our records. Its most recent split was on April 16, 2020, 6 years ago. Companies announce splits in advance, and any new TPEX:6564 split will appear on this page.
Already premium?